Embassy Developments Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 15, 2025, 8:38 pm

Quick Insight

Embassy Developments Ltd, with a current share price of ₹93.2 and a market capitalization of ₹12,728 Cr, operates in the Construction & Contracting industry. The company's financial metrics reveal a low Return on Equity (ROE) of 2.53% and Return on Capital Employed (ROCE) of 3.19%, indicating inefficiencies in utilizing shareholder funds. With an Operating Profit Margin (OPM) of -2%, Embassy faces operational challenges that may impact profitability. However, the company maintains a healthy Current Ratio of 9 days, indicating efficient working capital management.

Embassy's strong promoter holding of 42.44% and significant institutional ownership, with FIIs at 28.13% and DIIs at 3.66%, provide stability and confidence to investors. The company's Price-to-Book Value (P/BV) ratio of 1.52x suggests a reasonable valuation compared to industry peers. Despite a Net Profit of ₹194 Cr, Embassy's high borrowing levels of ₹4,594 Cr raise concerns about debt servicing capabilities, especially with an Interest Coverage Ratio (ICR) of 1.15x. Looking ahead, reducing debt levels and improving operational efficiency could enhance Embassy's financial health and long-term prospects in a competitive industry landscape.

In conclusion, while Embassy Developments Ltd demonstrates strong ownership structure and a relatively stable valuation, addressing operational inefficiencies and managing debt levels will be crucial for sustainable growth. Investors should closely monitor the company's efforts to improve profitability and reduce leverage to mitigate risks and capitalize on potential opportunities in the construction sector.

Competitors of Embassy Developments Ltd

All Competitor Stocks of Embassy Developments Ltd

Quarterly Result

Last Updated: August 21, 2025, 9:33 am

Below is a detailed analysis of the quarterly data for Embassy Developments Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 681.00 Cr.. The value appears to be declining and may need further review. It has decreased from 889.00 Cr. (Mar 2025) to 681.00 Cr., marking a decrease of 208.00 Cr..
• For Expenses, as of Jun 2025, the value is 692.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 881.00 Cr. (Mar 2025) to 692.00 Cr., marking a decrease of 189.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to -11.00 Cr., marking a decrease of 19.00 Cr..
• For OPM %, as of Jun 2025, the value is -2.00%. The value appears to be declining and may need further review. It has decreased from 1.00% (Mar 2025) to -2.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 265.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 252.00 Cr..
• For Interest, as of Jun 2025, the value is 160.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 139.00 Cr. (Mar 2025) to 160.00 Cr., marking an increase of 21.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -165.00 Cr.. The value appears to be declining and may need further review. It has decreased from 129.00 Cr. (Mar 2025) to -165.00 Cr., marking a decrease of 294.00 Cr..
• For Tax %, as of Jun 2025, the value is 1.00%. The value appears to be improving (decreasing) as expected. It has decreased from 5.00% (Mar 2025) to 1.00%, marking a decrease of 4.00%.
• For Net Profit, as of Jun 2025, the value is -166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 123.00 Cr. (Mar 2025) to -166.00 Cr., marking a decrease of 289.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.21. The value appears to be declining and may need further review. It has decreased from 1.06 (Mar 2025) to -1.21, marking a decrease of 2.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 15, 2025, 4:55 am

Growth

Last Updated: September 5, 2025, 7:05 am

Balance Sheet

Last Updated: September 10, 2025, 1:49 pm

Below is a detailed analysis of the balance sheet data for Embassy Developments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 244.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2024) to 244.00 Cr., marking an increase of 136.00 Cr..
• For Reserves, as of Mar 2025, the value is 9,077.00 Cr.. The value appears strong and on an upward trend. It has increased from -1,555.00 Cr. (Mar 2024) to 9,077.00 Cr., marking an increase of 10,632.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,594.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 7,749.00 Cr. (Mar 2024) to 4,594.00 Cr., marking a decrease of 3,155.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 6,572.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,637.00 Cr. (Mar 2024) to 6,572.00 Cr., marking an increase of 2,935.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 20,488.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,939.00 Cr. (Mar 2024) to 20,488.00 Cr., marking an increase of 10,549.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,089.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,737.00 Cr. (Mar 2024) to 6,089.00 Cr., marking an increase of 2,352.00 Cr..
• For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 98.00 Cr.. The value appears to be declining and may need further review. It has decreased from 867.00 Cr. (Mar 2024) to 98.00 Cr., marking a decrease of 769.00 Cr..
• For Other Assets, as of Mar 2025, the value is 14,291.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,335.00 Cr. (Mar 2024) to 14,291.00 Cr., marking an increase of 8,956.00 Cr..
• For Total Assets, as of Mar 2025, the value is 20,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,939.00 Cr. (Mar 2024) to 20,488.00 Cr., marking an increase of 10,549.00 Cr..

Notably, the Reserves (9,077.00 Cr.) exceed the Borrowings (4,594.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Embassy Developments Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 5. It has increased from -19.20 (Mar 24) to 1.69, marking an increase of 20.89.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 5. It has increased from -19.20 (Mar 24) to 1.43, marking an increase of 20.63.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 3. It has increased from -18.98 (Mar 24) to 1.78, marking an increase of 20.76.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.28. It has increased from 43.03 (Mar 24) to 76.28, marking an increase of 33.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.28. It has increased from 43.03 (Mar 24) to 76.28, marking an increase of 33.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.84. It has increased from 7.65 (Mar 24) to 17.84, marking an increase of 10.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.34. This value is within the healthy range. It has increased from -6.90 (Mar 24) to 4.34, marking an increase of 11.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.22. This value is within the healthy range. It has increased from -7.11 (Mar 24) to 4.22, marking an increase of 11.33.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from -18.90 (Mar 24) to 0.22, marking an increase of 19.12.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 2. It has increased from -19.19 (Mar 24) to 1.66, marking an increase of 20.85.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 2. It has increased from -19.20 (Mar 24) to 1.69, marking an increase of 20.89.
• For PBDIT Margin (%), as of Mar 25, the value is 24.35. This value is within the healthy range. It has increased from -90.17 (Mar 24) to 24.35, marking an increase of 114.52.
• For PBIT Margin (%), as of Mar 25, the value is 23.67. This value exceeds the healthy maximum of 20. It has increased from -92.91 (Mar 24) to 23.67, marking an increase of 116.58.
• For PBT Margin (%), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 10. It has increased from -247.17 (Mar 24) to 1.25, marking an increase of 248.42.
• For Net Profit Margin (%), as of Mar 25, the value is 9.30. This value is within the healthy range. It has increased from -250.93 (Mar 24) to 9.30, marking an increase of 260.23.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.46. This value is within the healthy range. It has increased from -251.00 (Mar 24) to 9.46, marking an increase of 260.46.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 15. It has increased from -44.60 (Mar 24) to 2.21, marking an increase of 46.81.
• For Return on Capital Employeed (%), as of Mar 25, the value is 3.84. This value is below the healthy minimum of 10. It has increased from -11.97 (Mar 24) to 3.84, marking an increase of 15.81.
• For Return On Assets (%), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has increased from -17.76 (Mar 24) to 1.00, marking an increase of 18.76.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.26, marking an increase of 0.15.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.12 (Mar 24) to 0.48, marking an increase of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.16. It has increased from 0.06 (Mar 24) to 0.16, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 2.06 (Mar 24) to 1.94, marking a decrease of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 24) to 0.23, marking a decrease of 0.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 3. It has increased from -40.39 (Mar 24) to 1.15, marking an increase of 41.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 3. It has increased from -43.29 (Mar 24) to 1.50, marking an increase of 44.79.
• For Enterprise Value (Cr.), as of Mar 25, the value is 18,274.92. It has increased from 6,459.17 (Mar 24) to 18,274.92, marking an increase of 11,815.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 3. It has decreased from 15.61 (Mar 24) to 8.38, marking a decrease of 7.23.
• For EV / EBITDA (X), as of Mar 25, the value is 34.41. This value exceeds the healthy maximum of 15. It has increased from -17.31 (Mar 24) to 34.41, marking an increase of 51.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.49. This value exceeds the healthy maximum of 3. It has decreased from 15.16 (Mar 24) to 6.49, marking a decrease of 8.67.
• For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 1.52, marking a decrease of 1.17.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.49. This value exceeds the healthy maximum of 3. It has decreased from 15.16 (Mar 24) to 6.49, marking a decrease of 8.67.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.16 (Mar 24) to 0.01, marking an increase of 0.17.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness